The American Psychiatric Association (APA) published a new guideline for Major Depressive Disorder (MDD) which will undoubtedly be used by many practitioners to guide clinical decision-making. In fact, it is non-psychiatrist clinicians who prescribe the majority of antidepressants (AD). We review the APA’s most recent guideline on MDD and report on our observations.
Cosgrove L., Shaughnessy A.F., Wheeler E.E., Austad K.E., Kirsch I, Bursztajn H.J., "The American Psychiatric Association’s Guideline for Major Depressive Disorder: A Commentary," Psychotherapy and Psychosomatics (2012), Volume 81, Pages 186–188.
© 2012 S. Karger AG, Basel
Mental Disorders Commons, Pharmacy Administration, Policy and Regulation Commons, Psychological Phenomena and Processes Commons
This is a post-print, pre-published version of a letter to the editor that was published in Psychotherapy and Psychosomatics (2012), Volume 81, Pages 186–188: Editor was http://dx.doi.org/10.1159/000335523/.